Pharma Insight ApS — Credit Rating and Financial Key Figures

CVR number: 40637117
Mathildevej 10, 2000 Frederiksberg

Income statement (kDKK)

2020
2021
2022
2023
Fiscal period length12121212
Net sales
Gross profit1 118.69725.06-27.01-17.12
Employee benefit expenses- 873.88- 661.50-1.25
EBIT244.8163.56-28.26-17.12
Other financial income0.952.410.18
Other financial expenses-2.38-1.94-0.76-1.92
Pre-tax profit242.4462.57-26.61-18.86
Income taxes-14.63
Net earnings242.4447.94-26.61-18.86

Assets (kDKK)

2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors110.44
Current amounts owed by group member comp.77.9282.82
Current other receivables3.673.243.09
Short term receivables total110.4481.5986.063.09
Cash and bank deposits388.47327.4469.7544.22
Cash and cash equivalents388.47327.4469.7544.22
Balance sheet total (assets)498.90409.03155.8147.31

Equity and liabilities (kDKK)

2020
2021
2022
2023
Share capital40.0040.0040.0040.00
Shares repurchased100.00100.00
Retained earnings-57.5684.8832.826.20
Profit of the financial year242.4447.94-26.61-18.86
Shareholders equity total224.88272.82146.2027.35
Non-current liabilities total
Current trade creditors17.0010.007.507.50
Current owed to participating15.9622.88
Current owed to group member5.5810.63
Short-term deferred tax liabilities51.9814.63
Other non-interest bearing current liabilities183.5188.702.111.84
Current liabilities total274.02136.219.6119.97
Balance sheet total (liabilities)498.90409.03155.8147.31
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.